Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Aastrom Biosciences

ClinicalTrials.gov Identifier:

NCT00765518

First received: October 2, 2008

Last updated: October 1, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2012
Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)